Neuroone Medical Technologies (NMTC) Debt Ratio (2010 - 2024)

Neuroone Medical Technologies' (NMTC) quarterly Debt Ratio came in at 0.05 in Q1 2024, up 41.7% quarter-over-quarter from 0.03 in Q3 2023.

Analysis

Neuroone Medical Technologies (NMTC) Debt Ratio (2010 - 2024) Analysis & Trends

Neuroone Medical Technologies (NMTC) has reported Debt Ratio for 13 consecutive years, with 0.05 the latest figure, recorded in Q1 2024.

For the quarter ending Q1 2024, Debt Ratio changed N/A year-over-year to 0.05; the trailing twelve-month figure through Mar 2024 stood at 0.05 (changed N/A YoY), and the FY2023 full-year result was 0.03, changed N/A from the prior year.
Debt Ratio grew to 0.05 in Q1 2024 per NMTC's latest filing, from 0.03 in the prior quarter.
Across five years, Debt Ratio topped out at 3.54 in Q1 2020 and bottomed at 0.03 in Q3 2023.
Historically, Debt Ratio has averaged 1.07 across 3 years, with a median of 0.21 in 2020.
The widest YoY moves for Debt Ratio: up 1104.86% in 2020, down 78.65% in 2020.
Over 3 years, Debt Ratio stood at 0.21 in 2020, then tumbled by 84.93% to 0.03 in 2023, then surged by 41.7% to 0.05 in 2024.
According to Business Quant data, Debt Ratio over the past three periods registered 0.05, 0.03, and 0.21 for Q1 2024, Q3 2023, and Q3 2020 respectively.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	0.30
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	-
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	0.30
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	0.31
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	0.28
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	0.04
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	0.13
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	-
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	0.20
10	Neuroone Medical Technologies	14.33 Mn	12.29 Mn	1.18 Mn	-

Historic Data

Download Data